InsiderFlow

NAUT

Healthcare

Nautilus Biotechnology, Inc.

$2.35+0.07 (+2.84%)

Prev Close

$2.29

Open

$2.26

High

$2.38

Low

$2.21

Volume

122.3K

Market Cap

$315.8M

P/E

—

Div Yield

—

Over the past 12 months, insider activity at Nautilus Biotechnology, Inc. (NAUT) has been exclusively buying, with 5 insider purchases totaling $241.6K and 0 insider sales totaling $0.00. The most recent insider transaction was by Patel Sujal M (director, 10 percent owner, officer: CEO, President, and Secretary), who purchased $130.5K worth of shares on Mar 4, 2026. Nautilus Biotechnology, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $315.8M.

Buys (12M)

5

$241.6K

Sells (12M)

0

$0.00

Net Activity

Net Buyer

$241.6K

Active Insiders

4

last 12 mo

NAUT Price Chart

NAUT Insider Trading Activity

DateInsiderRoleTypeSharesAvg PriceValueShares After
Mar 4, 2026↗Patel Sujal Mdirector, 10 percent owner, officer: CEO, President, and SecretaryBuy50,000$2.61$130.5K10,366,700
Sep 4, 2025↗Murphy Matthew B.General CounselBuy20,000$0.64$12.9K0
Jun 2, 2025↗Mowry AnnaCFO and TreasurerBuy15,000$0.77$11.5K83,000
May 12, 2025↗Mallick ParagChief ScientistBuy13,500$0.73$9.9K20,493,400
Mar 21, 2025↗Patel Sujal MCEO, President, and SecretaryBuy77,233$1.00$76.9K10,141,700
Sep 25, 2024↗Godwin Mary E.Senior VP, OperationsSell47,031$2.87$134.7K0
Sep 18, 2024↗Godwin Mary E.Senior VP, OperationsSell35,000$2.85$99.9K0
Mar 11, 2024↗Patel Sujal MCEO, President, and SecretaryBuy14,474$2.87$41.5K10,064,500
Mar 7, 2024↗Patel Sujal MCEO, President, and SecretaryBuy35,526$2.79$99.1K10,050,000
Sep 28, 2022↗Sankar SubramanianSenior VP, Product DevelopmentBuy15,000$2.03$30.4K91,250
Sep 26, 2022↗Weld Gwen EChief People OfficerBuy30,000$2.03$60.8K30,000
Sep 19, 2022↗Sankar SubramanianSenior VP, Product DevelopmentBuy75,000$2.18$163.2K75,000
Aug 22, 2022↗Mowry AnnaCFO and TreasurerBuy17,500$2.30$40.2K56,750
Aug 16, 2022↗Murphy Matthew B.General CounselBuy10,000$2.84$28.4K54,140
Aug 8, 2022↗Patel Sujal MCEO, President, and SecretaryBuy50,000$2.92$146.1K10,014,500
Jun 28, 2022↗Mowry AnnaCFO and TreasurerBuy5,500$2.75$15.1K39,250
May 10, 2022↗Patel Sujal MCEO, President, and SecretaryBuy50,000$3.96$198.0K9,964,490
Mar 4, 2022↗Patel Sujal MCEO, President, and SecretaryBuy50,000$3.60$179.9K9,914,390
Dec 10, 2021↗PERCEPTIVE ADVISORS LLCDirectorBuy200,000$5.36$1.07M9,111,150
Dec 2, 2021↗Patel Sujal MCEO, President, and SecretaryBuy250,000$4.72$1.18M9,864,390
Dec 1, 2021↗Posard Matthew L.DirectorBuy50,000$4.51$225.5K50,000
Nov 24, 2021↗Mowry AnnaCFO and TreasurerBuy15,000$4.58$68.6K32,500
Nov 17, 2021↗McIlwain Matthew SDirectorBuy100,000$5.30$529.9K459,075
Aug 26, 2021↗McIlwain Matthew SDirectorBuy36,970$7.71$285.0K359,075
Aug 16, 2021↗Mowry AnnaCFO and TreasurerBuy17,500$7.71$134.9K17,500
Aug 13, 2021↗Murphy Matthew B.General CounselBuy5,000$7.56$37.8K34,140
Jun 11, 2021↗PERCEPTIVE ADVISORS LLCBuy5,507,063$10.00$55.07M5,997,040

NAUT Insider Buying Activity

The following table shows recent insider purchases of Nautilus Biotechnology, Inc. (NAUT) stock reported via SEC Form 4 filings.

DateInsiderRoleTypeSharesAvg PriceValueShares After
Mar 4, 2026↗Patel Sujal Mdirector, 10 percent owner, officer: CEO, President, and SecretaryBuy50,000$2.61$130.5K10,366,700
Sep 4, 2025↗Murphy Matthew B.General CounselBuy20,000$0.64$12.9K0
Jun 2, 2025↗Mowry AnnaCFO and TreasurerBuy15,000$0.77$11.5K83,000
May 12, 2025↗Mallick ParagChief ScientistBuy13,500$0.73$9.9K20,493,400
Mar 21, 2025↗Patel Sujal MCEO, President, and SecretaryBuy77,233$1.00$76.9K10,141,700
Mar 11, 2024↗Patel Sujal MCEO, President, and SecretaryBuy14,474$2.87$41.5K10,064,500
Mar 7, 2024↗Patel Sujal MCEO, President, and SecretaryBuy35,526$2.79$99.1K10,050,000
Sep 28, 2022↗Sankar SubramanianSenior VP, Product DevelopmentBuy15,000$2.03$30.4K91,250
Sep 26, 2022↗Weld Gwen EChief People OfficerBuy30,000$2.03$60.8K30,000
Sep 19, 2022↗Sankar SubramanianSenior VP, Product DevelopmentBuy75,000$2.18$163.2K75,000
Aug 22, 2022↗Mowry AnnaCFO and TreasurerBuy17,500$2.30$40.2K56,750
Aug 16, 2022↗Murphy Matthew B.General CounselBuy10,000$2.84$28.4K54,140
Aug 8, 2022↗Patel Sujal MCEO, President, and SecretaryBuy50,000$2.92$146.1K10,014,500
Jun 28, 2022↗Mowry AnnaCFO and TreasurerBuy5,500$2.75$15.1K39,250
May 10, 2022↗Patel Sujal MCEO, President, and SecretaryBuy50,000$3.96$198.0K9,964,490
Mar 4, 2022↗Patel Sujal MCEO, President, and SecretaryBuy50,000$3.60$179.9K9,914,390
Dec 10, 2021↗PERCEPTIVE ADVISORS LLCDirectorBuy200,000$5.36$1.07M9,111,150
Dec 2, 2021↗Patel Sujal MCEO, President, and SecretaryBuy250,000$4.72$1.18M9,864,390
Dec 1, 2021↗Posard Matthew L.DirectorBuy50,000$4.51$225.5K50,000
Nov 24, 2021↗Mowry AnnaCFO and TreasurerBuy15,000$4.58$68.6K32,500
Nov 17, 2021↗McIlwain Matthew SDirectorBuy100,000$5.30$529.9K459,075
Aug 26, 2021↗McIlwain Matthew SDirectorBuy36,970$7.71$285.0K359,075
Aug 16, 2021↗Mowry AnnaCFO and TreasurerBuy17,500$7.71$134.9K17,500
Aug 13, 2021↗Murphy Matthew B.General CounselBuy5,000$7.56$37.8K34,140
Jun 11, 2021↗PERCEPTIVE ADVISORS LLCBuy5,507,063$10.00$55.07M5,997,040

NAUT Insider Selling Activity

The following table shows recent insider sales of Nautilus Biotechnology, Inc. (NAUT) stock reported via SEC Form 4 filings.

DateInsiderRoleTypeSharesAvg PriceValueShares After
Sep 25, 2024↗Godwin Mary E.Senior VP, OperationsSell47,031$2.87$134.7K0
Sep 18, 2024↗Godwin Mary E.Senior VP, OperationsSell35,000$2.85$99.9K0

NAUT Insiders

Patel Sujal M

director, 10 percent owner, officer: CEO, President, and Secretary

Bought $130.5K
2 tradesLast: Mar 4, 2026
Murphy Matthew B.

General Counsel

Bought $79.1K
4 tradesLast: Sep 4, 2025
Mowry Anna

CFO and Treasurer

Bought $270.4K
5 tradesLast: May 29, 2025
Mallick Parag

Chief Scientist

Bought $9.9K
2 tradesLast: May 12, 2025
Patel Sujal M

CEO, President, and Secretary

Bought $1.92M
13 tradesLast: Mar 20, 2025
Godwin Mary E.

Senior VP, Operations

Sold $234.6K
2 tradesLast: Sep 23, 2024
Sankar Subramanian

Senior VP, Product Development

Bought $193.6K
4 tradesLast: Sep 27, 2022
Weld Gwen E

Chief People Officer

Bought $60.8K
1 tradesLast: Sep 23, 2022
PERCEPTIVE ADVISORS LLC

Director

Bought $1.07M
1 tradesLast: Dec 8, 2021
Posard Matthew L.

Director

Bought $225.5K
4 tradesLast: Dec 1, 2021
McIlwain Matthew S

Director

Bought $814.9K
4 tradesLast: Nov 15, 2021
PERCEPTIVE ADVISORS LLC

Bought $55.07M
2 tradesLast: Jun 9, 2021

Similar Stocks to NAUT

VRTX

Vertex Pharmaceuticals Incorporated

$470.20-1.66%

$121.44B

REGN

Regeneron Pharmaceuticals, Inc.

$743.51-0.41%

$77.57B

ALNY

Alnylam Pharmaceuticals, Inc.

$313.45-1.19%

$42.07B

INSM

Insmed Incorporated

$139.06-0.33%

$30.07B

UTHR

United Therapeutics Corporation

$536.12+0.97%

$23.50B

MRNA

Moderna, Inc.

$52.56-1.89%

$20.76B

ROIV

Roivant Sciences Ltd.

$28.06-1.44%

$20.08B

RPRX

Royalty Pharma plc

$45.65-0.57%

$19.56B

Related Insider Trading Data

Healthcare Sector Insider TradingBiotechnology Insider TradingInsider BuyingCEO PurchasesCluster BuysWhat Is Insider Trading?